BR9706967A - Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa - Google Patents

Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa

Info

Publication number
BR9706967A
BR9706967A BR9706967A BR9706967A BR9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A
Authority
BR
Brazil
Prior art keywords
menopause
prophylaxis
compounds
treatment
symptoms related
Prior art date
Application number
BR9706967A
Other languages
English (en)
Inventor
Michael Shalmi
Niels Korsgaard
Birgitte Hjort Gudlhammer
James Robinson Piggott
Virender Mohan Labroo
Steven Bain
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9706967A publication Critical patent/BR9706967A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
BR9706967A 1996-01-11 1997-01-09 Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa BR9706967A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US983496P 1996-01-11 1996-01-11
US67826196A 1996-07-11 1996-07-11
PCT/DK1997/000008 WO1997025035A1 (en) 1996-01-11 1997-01-09 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms

Publications (1)

Publication Number Publication Date
BR9706967A true BR9706967A (pt) 1999-05-04

Family

ID=26679921

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9706967A BR9706967A (pt) 1996-01-11 1997-01-09 Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa

Country Status (12)

Country Link
EP (1) EP0873120A1 (pt)
JP (1) JP2000506505A (pt)
KR (1) KR19990077156A (pt)
AU (1) AU1367297A (pt)
BR (1) BR9706967A (pt)
CA (1) CA2241623A1 (pt)
CZ (1) CZ217298A3 (pt)
HU (1) HUP9902683A3 (pt)
IL (1) IL124882A0 (pt)
NO (1) NO983178L (pt)
PL (1) PL327831A1 (pt)
WO (1) WO1997025035A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
DE60018215T2 (de) * 1999-12-30 2006-02-09 Signal Pharmaceuticals Llc, San Diego Verbindungen und verfahren zur modulation von estrogen rezeptoren
CN101056868B (zh) 2004-09-21 2012-05-02 马休爱德华兹股份有限公司 取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CN102357248A (zh) 2004-10-20 2012-02-22 恩多研究公司 单独的性甾体前体或与选择性***受体调节剂联合用于防治绝经后女性的***疾病和病症
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CA2702710C (en) 2007-10-16 2013-05-07 Repros Therapeutics, Inc. Trans-clomiphene for metabolic syndrome
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
BR112012032189B1 (pt) 2010-06-16 2020-11-03 Endorecherche, Inc usos de um agonista ou antagonista de lhrh em associação com um modulador de receptor de estrogênio seletivo e com um precursor de esteróide sexual para a preparação de uma medicamento para o tratamento ou prevenção de doenças relacionadas com estrogênio e kits
JP6013349B2 (ja) 2010-11-01 2016-10-25 メイ ファーマ, インク.Mei Pharma, Inc. 癌の処置のためのイソフラボノイド化合物および方法
CA2865234A1 (en) 2012-02-29 2013-09-06 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
EP2953938B1 (en) 2014-02-07 2017-08-02 Novogen Ltd. Functionalised benzopyran compounds and use thereof
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra
AU2016352592B2 (en) 2015-11-10 2023-04-27 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency

Also Published As

Publication number Publication date
HUP9902683A2 (hu) 2001-04-28
WO1997025035A1 (en) 1997-07-17
KR19990077156A (ko) 1999-10-25
AU1367297A (en) 1997-08-01
HUP9902683A3 (en) 2001-08-28
CA2241623A1 (en) 1997-07-17
JP2000506505A (ja) 2000-05-30
CZ217298A3 (cs) 1999-01-13
IL124882A0 (en) 1999-01-26
EP0873120A1 (en) 1998-10-28
NO983178L (no) 1998-07-10
PL327831A1 (en) 1999-01-04

Similar Documents

Publication Publication Date Title
BR9706967A (pt) Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa
BR9400571A (pt) Processo para o tratamento de despejo orgânico
PT712860E (pt) Processo para purificacao e isolamento de 2'-deoxi-2', 2'-difluoronucleosidos
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
BR9503624A (pt) Processo de preparação de compostos aromáticos
BR9408407A (pt) Uso de inibidores pla2 como tratamento para doença de alzheimer
BR9305274A (pt) Processo para tratar leite cru
BR9400177A (pt) Processo e dispositivo para evacuação des resíduos sólidos
BR9204375A (pt) Composicao e processo para o tratamento de agua de refrigeracao
BR9708093A (pt) Composto formulação uso composto e processo para tratamento de distúrbios mediados por 5-hidroxitriptamina e para preparação do composto
BR9506473A (pt) Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas
BR9506271A (pt) Processo para o tratamento de aves domésticas
BR9400368A (pt) Processo para isolamento e purificação de trehalose
PT96725A (pt) Processo para o tratamento de graos de cacau
BR9708908A (pt) Processo para tratamento de inflamação
BR9607346A (pt) Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos
BR9106377A (pt) Composicao e processo para o tratamento topico de tecido lesado ou enfermo
BR9505700A (pt) Processo para e preparação contínua de isocianatos orgânicos
PT1345944E (pt) Processo para o isolamento e purificacao de epotilonas
BR9602657A (pt) Processo para tratamento de resíduo de bauxita de lama vermelha e descarte de resíduo de lama vermelha
PT1068162E (pt) Processo para remocao de impurezas de argilas de caulino
BR9606766A (pt) Utilização de compostos e processo para o tratamento e profilaxia de disturbios degenerativos cerebrais
BR9502184A (pt) Composições cosmeticas de uso tópico utilização de composições processo de tratamento cosmético
BR9002081A (pt) Processo e aparelho para o tratamento de detritos organicos
BR9606925A (pt) Utilização de compostos e processo para o tratamento e profilaxia da obesidade

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]